Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-23 Sale | 2023-01-25 5:29 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 24,661 | $0.5978 | $14,742 | 513,204 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:28 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 17,769 | $0.5978 | $10,622 | 324,736 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:26 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 12,663 | $0.5978 | $7,570 | 214,848 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:25 pm | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 35,453 | $0.5978 | $21,194 | 866,127 (Indirect Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:08 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 8,281 | $1.1 | $9,109 | 367,865 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:06 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 4,289 | $1.1 | $4,718 | 107,511 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:05 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 6,013 | $1.1 | $6,614 | 172,505 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 4:05 pm | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & CEO | 11,899 | $1.1 | $13,089 | 651,580 (Indirect Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:53 pm | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 40 | $1.01 | $40 | 62,732 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:52 pm | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 40 | $1.01 | $40 | 62,732 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:51 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 40 | $1.01 | $40 | 62,732 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:50 pm | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 40 | $1.01 | $40 | 62,732 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:49 pm | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 40 | $1.01 | $40 | 62,732 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:48 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 53 | $1.01 | $54 | 67,719 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-31 Option Award | 2023-02-02 8:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 42,437 | $0 | 896,838 (Direct) | View |
| 2023-01-31 Tax Withholding | 2023-02-02 8:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 11,726 | $0.5952 | 896,838 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 17,631 | $0 | 216,790 (Direct) | View |
| 2023-01-31 Tax Withholding | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 5,841 | $0.5952 | 216,790 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 13,950 | $0 | 223,989 (Direct) | View |
| 2023-01-31 Tax Withholding | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 4,809 | $0.5952 | 223,989 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 21,073 | $0 | 339,882 (Direct) | View |
| 2023-01-31 Tax Withholding | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 5,927 | $0.5952 | 339,882 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 33,688 | $0 | 537,571 (Direct) | View |
| 2023-01-31 Tax Withholding | 2023-02-02 8:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 9,321 | $0.5952 | 537,571 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:30 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 170,000 | $0 | 205,000 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:29 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 170,000 | $0 | 513,204 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:28 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 170,000 | $0 | 324,736 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:26 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 120,000 | $0 | 214,848 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:25 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 250,000 | $0 | 866,127 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 30,000 | $0 | 367,865 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 14,800 | $0 | 107,511 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:05 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 20,800 | $0 | 172,505 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:05 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & CEO | 43,164 | $0 | 651,580 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:53 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 57,772 | $0 | 62,732 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:52 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 57,772 | $0 | 62,732 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:51 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 57,772 | $0 | 62,732 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:50 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 57,772 | $0 | 62,732 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:49 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 57,772 | $0 | 62,732 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:48 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 57,772 | $0 | 67,719 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-15 4:13 pm | N/A 2032-02-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 235,000 | $0 | 235,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:28 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 310,000 | $0 | 810,315 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:18 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 210,000 | $0 | 282,718 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:16 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 150,000 | $0 | 187,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:14 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 210,000 | $0 | 471,146 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:29 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:28 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 12,500 | $0 | 17,500 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:27 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:25 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:23 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:21 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:22 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 130,000 | $0 | 150,718 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:21 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 269,778 | $0 | 662,182 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:19 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 185,000 | $0 | 371,146 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:15 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP Commercial & Business Dev. | 92,000 | $0 | 92,000 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:14 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Hanlon Suzanne M. Sec VP & General Counsel | 92,000 | $0 | 135,693 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 5:42 pm | N/A 2030-06-10 | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 5:40 pm | N/A 2030-06-10 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 5:38 pm | N/A 2030-06-10 | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 15,000 | $0 | 15,000 (Direct) | View |